ArticleTechnical innovations & patient support in radiation oncology2026
Decreased overall survival in patients with brain metastases from non-small cell lung cancer with radiotherapy dose on the neurogenic niches.
Article in Technical innovations & patient support in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Negative impact of hippocampal radiotherapy dose on memory function in patients with brain metastases.Neuro-oncology practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-small cell lung cancer (NSCLC), the most common type of lung cancer frequently leads to brain metastases (BMs), which are associated with a poor prognosis. Radiotherapy is the main treatment for BMs, but irradiates healthy tissue, including neural stem cells (NSCs). NSCs reside in neurogenic niches, mainly the subventricular zone (SVZ) and the subgranular zone (SGZ) within the hippocampus (HPC), which support neurogenesis and brain repair. Radiation damage to NSCs may influence overall survival (OS). Our study aims to evaluate the impact of any radiotherapy dose on NSCs on OS in patients with BMs from NSCLC, with lesion contact explored as a secondary aim. Methods: We retrospectively included 138 NSCLC patients with BMs and delineated NSC regions on T1 MR-images. Kaplan-Meier (KM) analysis and Cox regression assessed associations between OS, mean radiotherapy dose to SVZ and HPC, and lesion contact. Results: Higher radiotherapy dose on the SVZ and HPC were significantly associated with reduced OS, with a hazard ratio (HR) of 1.306 ([95% CI 1.043-1.635], p = 0.019) and 1.222 ([95% CI 1.008-1.483], p = 0.041), respectively. Lesion contact with neurogenic niches was also independently significant (SVZ: HR 1.968 [95% CI 1.094-3.542], p = 0.023 and HPC: HR 5.751 [95% CI 1.733-19.07], p = 0.004), although lesion contact was uncommon. Conclusion: Unintended radiotherapy dose to neurogenic niches is independently associated with worse OS in NSCLC patients with brain metastases, and tumor contact with these regions also shows an adverse association. These findings support considering the SVZ and hippocampus as organs-at-risk in SRS planning and motivate prospective validation in larger, controlled cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.